PH17981A - Nonapeptide for the treatment of drug withdrawal symtoms - Google Patents

Nonapeptide for the treatment of drug withdrawal symtoms

Info

Publication number
PH17981A
PH17981A PH27299A PH27299A PH17981A PH 17981 A PH17981 A PH 17981A PH 27299 A PH27299 A PH 27299A PH 27299 A PH27299 A PH 27299A PH 17981 A PH17981 A PH 17981A
Authority
PH
Philippines
Prior art keywords
nonapeptide
treatment
drug withdrawal
symtoms
withdrawal symtoms
Prior art date
Application number
PH27299A
Other languages
English (en)
Inventor
Richard Raimund Scherschlight
Rene Prof Dr Tissot
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH17981A publication Critical patent/PH17981A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH27299A 1981-05-21 1982-05-14 Nonapeptide for the treatment of drug withdrawal symtoms PH17981A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH330681 1981-05-21

Publications (1)

Publication Number Publication Date
PH17981A true PH17981A (en) 1985-02-26

Family

ID=4253131

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27299A PH17981A (en) 1981-05-21 1982-05-14 Nonapeptide for the treatment of drug withdrawal symtoms

Country Status (11)

Country Link
US (2) US4444758A (fr)
EP (1) EP0065747B1 (fr)
JP (1) JPS5823630A (fr)
AU (1) AU552547B2 (fr)
CA (1) CA1188989A (fr)
DE (1) DE3218761A1 (fr)
IE (1) IE53395B1 (fr)
IL (1) IL65782A (fr)
IT (1) IT1152116B (fr)
PH (1) PH17981A (fr)
ZA (1) ZA823369B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency
US5403595A (en) * 1991-05-07 1995-04-04 Dynagen, Inc. Controlled, sustained release delivery system for smoking cessation
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
ATE265213T1 (de) * 1997-09-04 2004-05-15 Novoneuron Inc Noribogain zur behandlung von schmerzen und drogenabhängigkeit
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
BR0008046A (pt) * 1999-02-05 2001-11-06 Univ Manchester Usos de um peptìdeo indutor de sono delta ou derivados e fragmentos biologicamente do mesmo e de um composto que diminui a atividade de peptìdeo indutor de sono delta e método de avaliar as necessidades anestésicas de um indivìduo a ser anestesiado
DE10014007A1 (de) * 2000-03-22 2001-10-11 Strathmann Ag & Co Neue Darreichungsformen für DSIP
RU2005128993A (ru) * 2005-09-08 2007-03-20 Общество С Ограниченной Ответственностью Исследовательский Центр "Комкон" (Ru) Средство для коррекции стресс-индуцируемых нейромедиаторных, нейроэндокринных и метаболических нарушений, а также способ профилактики и лечения сопутствующих им паталогических состояний
CA2699026A1 (fr) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Utilisation d'un peptide en tant qu'agent therapeutique
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
MX2013000733A (es) 2010-07-23 2013-05-30 Demerx Inc Composiciones de noribogaina.
EP2481740B1 (fr) 2011-01-26 2015-11-04 DemeRx, Inc. Procédés et compositions pour préparer de la noribogaïne à partir de voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
WO2013085922A1 (fr) 2011-12-09 2013-06-13 Demerx, Inc. Esters phosphoriques de noribogaïne
WO2013112673A1 (fr) 2012-01-25 2013-08-01 Demerx, Inc. Voacangine synthétique
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US9783535B2 (en) 2012-12-20 2017-10-10 Demerx, Inc. Substituted noribogaine
WO2015195673A2 (fr) 2014-06-18 2015-12-23 Demerx, Inc. Dérivés d'indole et de benzofurane halogénés d'isoquinuclidène et procédés pour leur préparation.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634331A5 (de) * 1977-06-30 1983-01-31 Hoffmann La Roche Phosphorylierte nonapeptide und verfahren zu deren herstellung.

Also Published As

Publication number Publication date
EP0065747A1 (fr) 1982-12-01
IL65782A (en) 1985-08-30
AU8375682A (en) 1982-11-25
AU552547B2 (en) 1986-06-05
US4496545A (en) 1985-01-29
DE3218761A1 (de) 1982-12-16
JPS5823630A (ja) 1983-02-12
IT8221072A0 (it) 1982-05-04
JPH0354089B2 (fr) 1991-08-19
CA1188989A (fr) 1985-06-18
US4444758A (en) 1984-04-24
ZA823369B (en) 1983-03-30
IL65782A0 (en) 1982-08-31
DE3218761C2 (fr) 1993-05-06
IT1152116B (it) 1986-12-31
IE821214L (en) 1982-11-21
EP0065747B1 (fr) 1986-10-15
IE53395B1 (en) 1988-11-09

Similar Documents

Publication Publication Date Title
PH17981A (en) Nonapeptide for the treatment of drug withdrawal symtoms
EG18268A (en) Medicament for the treatment of inflammation of the eye
GB2100605B (en) Bandage for administering drugs.
IL64001A0 (en) Blood treatment system
DE3375712D1 (en) System for externally treating the blood
DE3274187D1 (en) Anti-inflammatory ophthalmic solution and process for preparing the same
MY8500514A (en) The treatment of aqueous systems
GB2116042B (en) Injector for medical uses
HU178841B (en) Cattle-leader for the prophylactic or therapeutic treatment of cattle
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
DE3273455D1 (en) Fire-resistant support for the human body
PH19173A (en) The treatment of aqueous system
GB2220352B (en) Medicaments for the treatment of emesis
GB9103278D0 (en) Drug for the treatment of dermatitis
GB2216414B (en) Medicaments for the treatment of emesis
JPS57139016A (en) Burn patient medicine
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
ZA825302B (en) Medicine for the treatment of diabetes
EP0412938A3 (en) System for the treatment of contactlenses
PH17582A (en) Pharmaceutical compositions for the treatment of diabetes
DE3366025D1 (en) Medicine for the treatment of the neoplazic disease
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
JPS57153661A (en) Therapeutic container
AU1705783A (en) Medicine for the treatment of the neoplazic disease

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 12